Gritstone Oncology Inc diskutieren
Gritstone Oncology Inc
WKN: A2N4RX / Symbol: GRTS / Name: Gritstone Oncology / Aktie / Pharmazeutika / Small Cap /
0,73 €
-2,64 %
Gritstone bio, Inc. (NASDAQ: GRTS) is now covered by analysts at B. Riley. They set a "buy" rating and a $8.00 price target on the stock.
Ratings data for GRTS provided by MarketBeat
Gritstone bio, Inc. (NASDAQ: GRTS) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
Ratings data for GRTS provided by MarketBeat
Gritstone bio, Inc. (NASDAQ: GRTS) had its price target raised by analysts at Piper Sandler from $6.00 to $7.00. They now have an "overweight" rating on the stock.
Ratings data for GRTS provided by MarketBeat
Gritstone bio, Inc. (NASDAQ: GRTS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Ratings data for GRTS provided by MarketBeat
Gritstone bio, Inc. (NASDAQ: GRTS) had its price target lowered by analysts at HC Wainwright from $7.00 to $4.00. They now have a "buy" rating on the stock.
Ratings data for GRTS provided by MarketBeat
Gritstone bio, Inc. (NASDAQ: GRTS) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $3.00 price target on the stock, down previously from $6.00.
Ratings data for GRTS provided by MarketBeat
Neueste Beiträge
StockNews_com in Digital Ally Inc. diskutieren, Digital Ally Inc.new